Showing results (61-70 of 1,804) with videos related to
Sort By:
Pageof 181
Life Sciences|June 29, 1987
Erythrocyte 3H-ouabain binding and digitalis treatment in ethanol addicted patientsF Battaini, S Govoni, A Mauri, et al.La Medicina Del Lavoro|January 1, 1991
[The use of 1,1,1-trichloroethane (methylchloroform) in industrial operations: the neurotoxicity risk]C Fernicola, S Govoni, L Coniglio, et al.Pharmacological Research Communications|February 1, 1983
Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNSM Memo, S Govoni, E Carboni, et al.Stroke|January 1, 1988
Aging modifies the asymmetry in brain microvascular regulationM S Magnoni, S Govoni, H Kobayashi, et al.Life Sciences|December 17, 1984
Correlation between beta-endorphin/beta-lipotropin-immunoreactivity and cortisol plasma concentrationsS Govoni, G Pasinetti, M R Inzoli, et al.Mechanisms of Ageing and Development|January 1, 1980
Impairment of brain neurotransmitter receptors in aged ratsS Govoni, M Memo, L Saiani, et al.Neurobiology of Aging|January 1, 1983
Decreased content of met-enkephalin-like peptides in superior cervical and coeliac ganglia of aged ratsS Govoni, C Missale, L Castelletti, et al.Neurobiology of Aging|July 1, 1990
Omegaconotoxin binding decreases in aged rat brainR M Moresco, S Govoni, F Battaini, et al.Minerva Medica|June 8, 1986
[Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy]S Govoni, M Trabucchi, F Battaini, et al.Journal of Neural Transmission. General Section|January 1, 1990
Calcium antagonists inhibit met-enkephalin immunoreactive material release: in vitro and ex vivo experimentsS Govoni, I Goss, S Di Giovine, et al.Pageof 181